Skip to main content

Charles M Rice

NIH Rank #545
  • Top 5% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 1891549Search this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Microbiology & Immunology

NIH Funding · FY2026

Linked Award Amount
$5.1M
Full award amounts, FY2026
Award Records
7
Records listing this PI
Award-Linked Rank
#545
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Charles M Rice. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Charles M Rice as a PI. Multi-PI records show the full award amount for context.

  • 1R01AI190067-01A1R01
    Elucidating the host and viral determinants of treatment response in chronic hepatitis B
    $862.7K
    award amount
  • 5R01AI124690-10R01
    Unraveling yellow fever 17D vaccine attenuation: The role of type I interferon and innate immunity
    $846.8K
    award amount
  • 5R01AI183884-03R01
    Breaching the species barrier: Towards an immunocompetent HBV-susceptible mouse model
    $786.7K
    award amount
  • 5R01AI150275-07R01
    Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology
    $711.7K
    award amount
  • 5R01AI175382-04R01
    Employing viruses to unravel the functional significance of the m5C epitranscriptome
    $648.8K
    award amount
  • 5R01AI161444-05R01
    Tracking SARS-CoV-2 one molecule at a time: Spatiotemporal investigation of coronavirus replication dynamics and host response in single cells in vitro and in vivo
    $619.9K
    award amount
  • 5R01AI158676-05R01
    A clear view of encephalitis: a single cell approach to determine the basis of flaviviral pathogenesis in the central nervous system
    $579.1K
    award amount

Award organization

Organizations that administered FY2026 awards listing Charles M Rice as a PI.

FY2026 award administered by Rockefeller University (NY).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Rockefeller University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    Entered Top 50% Nationally
    Ranked #960
  7. 2024
    Entered Top 25% Nationally
    Ranked #960
  8. 2024
    Entered Top 10% Nationally
    Ranked #960
  9. 2024
    Entered Top 5% Nationally
    Ranked #960
  10. 2025
    $10M Cumulative Funding
  11. 2025
    R01 Grant Holder

Shared-award investigators

Other investigators listed on at least one of the same NIH award records as Charles M Rice.